CancerAlmanac

A Global Oncologist-Led Intelligence Platform on Cancer Innovation

Founded by a distributed network of 32 practicing oncologists across multiple continents, CancerAlmanac is an independent, clinician-led initiative focused on tracking and analyzing advances in oncology.

Our Focus

We monitor and interpret developments across:

• Artificial Intelligence in Oncology
• Emerging Therapeutics (Immunotherapy, CAR-T, ADCs, mRNA platforms)
• Landmark Clinical Trials and Major Publications
• Biotech and Pharmaceutical Industry Movements
• Profiles of Leading Researchers and Innovators

Editorial Principles

CancerAlmanac is built on evidence-based analysis, clinical expertise, and editorial independence. Our mission is to provide clear, structured, and responsible insight into the rapidly evolving oncology landscape.

We are currently in our foundational release phase. Full publication cadence will begin in 2026.